Circulating stromal cells in resectable pancreatic cancer correlates to pathological stage and predicts for poor clinical outcomes | npj Precision Oncology
Markers of pancreatic cancer stem cells and their clinical and therapeutic implications | SpringerLink
Frontiers | Predictive Biomarkers for a Personalized Approach in Resectable Pancreatic Cancer
Markers of pancreatic cancer stem cells and their clinical and therapeutic implications | SpringerLink
Pancreatic Cancer CT: Prediction of Resectability according to NCCN Criteria | Radiology
Frontiers | CA19.9 Serum Level Predicts Lymph-Nodes Status in Resectable Pancreatic Ductal Adenocarcinoma: A Retrospective Single-Center Analysis
Consensus guidelines for diagnosis, treatment and follow-up of patients with pancreatic cancer in Spain | SpringerLink
New Treatment Options and Management Considerations in Borderline Resectable Pancreatic Cancer
Identification of candidate diagnostic and prognostic biomarkers for pancreatic carcinoma - eBioMedicine
Identification and prognostic analysis of biomarkers to predict the progression of pancreatic cancer patients | Molecular Medicine | Full Text
Selective Labeling and Identification of the Tumor Cell Proteome of Pancreatic Cancer In Vivo | Journal of Proteome Research
Trends in Neoadjuvant Approaches in Pancreatic Cancer in: Journal of the National Comprehensive Cancer Network Volume 15 Issue 8 (2017)
Pancreatic Cancer Tumor Markers | GeneTex
Identification and prognostic analysis of biomarkers to predict the progression of pancreatic cancer patients | Molecular Medicine | Full Text
Identification and prognostic analysis of biomarkers to predict the progression of pancreatic cancer patients | Molecular Medicine | Full Text
Resectable and Borderline Resectable Pancreatic Cancer | SpringerLink
What Makes a Pancreatic Cancer Resectable? | American Society of Clinical Oncology Educational Book
Locally Advanced Pancreatic Cancer | MDedge Hematology and Oncology
Circulating stromal cells in resectable pancreatic cancer correlates to pathological stage and predicts for poor clinical outcomes | npj Precision Oncology
Circulating stromal cells in resectable pancreatic cancer correlates to pathological stage and predicts for poor clinical outcomes | npj Precision Oncology
Identification and prognostic analysis of biomarkers to predict the progression of pancreatic cancer patients | Molecular Medicine | Full Text
New Treatment Options and Management Considerations in Borderline Resectable Pancreatic Cancer
Identification and prognostic analysis of biomarkers to predict the progression of pancreatic cancer patients | Molecular Medicine | Full Text
Pancreatic Cancer CT: Prediction of Resectability according to NCCN Criteria | Radiology
Selective Labeling and Identification of the Tumor Cell Proteome of Pancreatic Cancer In Vivo | Journal of Proteome Research
Circulating tumor DNA as a prognostic indicator in resectable pancreatic ductal adenocarcinoma: A systematic review and meta-analysis | Scientific Reports